Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Joyce, John [R-PA-13]

Rep. Joyce, John [R-PA-13]

United States · Official source

Memberships

  • · House of Representatives · present
  • R · R · present

Showing the 24 most recent votes of 2,528. Browse the full list

Bill· HRH.R. 10645 (119th)referred

SMART Act

United States · United States Congress · 1 October 2026

Bill· HRH.R. 9970 (119th)referred

RESCUE Act of 2026

United States · United States Congress · 27 July 2026

Bill· HJRESH.J.Res. 205 (119th)referred

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's Advanced Clean Car Program and a Within the Scope Confirmation for California's Zero Emission Vehicle Amendments for 2017 and Earlier Model Years".

United States · United States Congress · 23 July 2026

Bill· HRH.R. 9829 (119th)referred

ORTHO Act

United States · United States Congress · 22 July 2026

Bill· HRH.R. 9599 (119th)referred

SECURE 340B Act

United States · United States Congress · 6 July 2026

Bill· HRH.R. 9418 (119th)referred

Access to Innovative Treatments Act of 2026

United States · United States Congress · 24 June 2026

Access to Innovative Treatments Act of 2026 This bill requires the Centers for Medicare & Medicaid Services (CMS) to review adverse national coverage determinations of drugs under Medicare within 30 days of receiving a request to do so. Specifically, the CMS must review within 30 days any denials or limitations of coverage that are inconsistent with the drug's approval by the Food and Drug Administration (FDA). The bill's requirements do not apply if the CMS already conducted such a review within a two-year period. The bill also prohibits the CMS from applying prior coverage determinations that were made for drugs before they were approved by the FDA if such determinations are inconsistent with the drug's approval.

Bill· HRH.R. 9002 (119th)referred

SURS Extension Act

United States · United States Congress · 21 May 2026

Small Practice, Underserved, and Rural Support Program Extension Act of 2023 or the SURS Extension Act This bill reauthorizes funds through FY2031 for the Centers for Medicare & Medicaid Services to contract with specified entities (e.g., quality improvement organizations) to provide technical assistance regarding the Merit-based Incentive Payment System (MIPS) and alternative payment models under Medicare, specifically for health professionals in practices with 15 or fewer professionals. (MIPS is an incentive program under Medicare that allows health professionals to receive payment adjustments based on certain performance measures.)

Bill· HRH.R. 8413 (119th)referred

SECURE Data Act

United States · United States Congress · 21 April 2026

Bill· HRH.R. 8414 (119th)referred

DAIRY PRIDE Act

United States · United States Congress · 21 April 2026

Showing the 24 most recent records of 891. Browse the full list